Skip to main content
National Screening Unit
National Screening Unit
  • Contact us
  • Publications
  • News
  • Home
  • About Us
    • Contact us
    • What is screening?
    • Screening programmes
    • Achieving our vision
    • Quality improvement
    • Advisory groups
    • Recommended links
    • Informed consent
    • About this site
  • Pregnancy & Newborn Screening
    • COVID-19: Information for pregnancy and newborn screening participants
    • Antenatal Screening for Down syndrome and Other Conditions
    • Newborn Metabolic Screening Programme - heel prick test
    • Universal Newborn Hearing Screening Programme
  • Bowel Screening
  • Breast & Cervical Screening
  • For Health Professionals
    • COVID-19: Information for screening providers
    • Antenatal Screening for Down syndrome and other Conditions
    • BreastScreen Aotearoa
    • National Bowel Screening Programme
    • National Cervical Screening Programme
    • Newborn Metabolic Screening Programme
    • Universal Newborn Hearing Screening Programme
    • Tools and resources
  1. Home
  2. Publications
  3. A summary of the BreastScreen Aotearoa Mortality Evaluation 1999–2011

A summary of the BreastScreen Aotearoa Mortality Evaluation 1999–2011

Image preview of A summary of the BreastScreen Aotearoa Mortality Evaluation 1999–2011 resource
December, 2015
This document provides an overview of the recently published BreastScreen Aotearoa (BSA) mortality evaluation, which assessed the impact of New Zealand’s breast screening programme from 1999 to 2011 on breast cancer mortality.

View publication:

  • A summary of the BreastScreen Aotearoa Mortality Evaluation 1999–2011 (pdf, 481 KB)
  • Home
  • Contact
  • Feedback
  • Glossary
  • Disclaimer
  • Privacy
  • Copyright
  • Accessibility
  • Publications
  • News
  • Ministry of Health
  • Time to Screen
govt.nz (opens in a new window). health.govt.nz website (opens in a new window).

© National Screening Unit 2023

Back to top